| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027278863 |
| P356 | DOI | 10.1007/S11897-014-0186-8 |
| P698 | PubMed publication ID | 24493574 |
| P5875 | ResearchGate publication ID | 260091504 |
| P50 | author | Matteo Casenghi | Q85643146 |
| Roberta Coluccia | Q114403749 | ||
| Erica Gabriele | Q114577174 | ||
| Massimo Volpe | Q37829227 | ||
| Speranza Donatella Rubattu | Q42806790 | ||
| Vittoria Mastromarino | Q57211306 | ||
| P2093 | author name string | Marco Testa | |
| P2860 | cites work | Challenges for improving medication adherence | Q79354339 |
| Predictors of adherence with antihypertensive and lipid-lowering therapy | Q81777601 | ||
| Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone | Q83169026 | ||
| The implications of therapeutic complexity on adherence to cardiovascular medications | Q84069362 | ||
| Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 | ||
| Structured telephone support or telemonitoring programmes for patients with chronic heart failure | Q24236592 | ||
| Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States | Q24657307 | ||
| Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study | Q28291971 | ||
| The challenge of polypharmacy in cardiovascular medicine. | Q30381521 | ||
| Polytherapy in cardiovascular prevention: open issues | Q30419040 | ||
| A systematic review of the associations between dose regimens and medication compliance | Q30719289 | ||
| Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age. | Q33163274 | ||
| Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications | Q33676719 | ||
| Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice | Q33707148 | ||
| The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. | Q34458624 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Prescribing amiodarone: an evidence-based review of clinical indications | Q34690065 | ||
| Medication Adherence Among Community-Dwelling Patients With Heart Failure | Q34748351 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association | Q35000500 | ||
| Nonsteroidal anti-inflammatory drugs and heart failure | Q35091934 | ||
| Preventable causative factors leading to hospital admission with decompensated heart failure | Q35369642 | ||
| Telemonitoring in patients with heart failure | Q35611446 | ||
| Trends in comorbidity, disability, and polypharmacy in heart failure | Q35611459 | ||
| How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials | Q35743893 | ||
| Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge | Q35789310 | ||
| Optimising drug treatment for elderly people: the prescribing cascade | Q36246842 | ||
| Health outcomes and polypharmacy in elderly individuals: an integrated literature review. | Q36270579 | ||
| ??? | Q28267062 | ||
| Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. | Q36393927 | ||
| Relationship between polypharmacy and underprescribing | Q36536061 | ||
| The association between COPD and heart failure risk: a review | Q36980625 | ||
| Medication adherence in patients who have heart failure: a review of the literature | Q37076851 | ||
| Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials | Q37584696 | ||
| Pharmacotherapy of heart failure in the elderly: adverse events | Q37891877 | ||
| Role of self-care in the patient with heart failure | Q37995891 | ||
| Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study | Q38492900 | ||
| National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q39513412 | ||
| A prescription for better prescribing | Q42758452 | ||
| Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality | Q42781665 | ||
| Relationship between psychosocial variables and compliance in patients with heart failure. | Q43671099 | ||
| Treatment adherence and risk of death after a myocardial infarction | Q45052662 | ||
| Spectrum of heart failure in older patients: results from the National Heart Failure project | Q45289008 | ||
| Polypharmacy and prescribing quality in older people | Q46248077 | ||
| Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial | Q47437725 | ||
| B-type natriuretic peptide-guided heart failure therapy: A meta-analysis | Q48263615 | ||
| Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study | Q48886642 | ||
| The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure | Q48971321 | ||
| Adverse drug events as a cause of hospital admission in the elderly | Q49281714 | ||
| Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology | Q50439772 | ||
| Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) Trial | Q50908731 | ||
| Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure | Q51651078 | ||
| Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas | Q51960346 | ||
| Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I. | Q53244601 | ||
| Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. | Q53643383 | ||
| Heart failure | Q53998058 | ||
| Heart Failure | Q56593772 | ||
| Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure | Q57266872 | ||
| Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure | Q57689723 | ||
| Negative Clinical Outcomes Associated With Drug-Related Problems in Heart Failure (HF) Outpatients: Impact of a Pharmacist in a Multidisciplinary HF Clinic | Q60638657 | ||
| The perindopril in elderly people with chronic heart failure (PEP-CHF) study | Q61716699 | ||
| The Effects of Polypharmacy in Older Adults | Q61828922 | ||
| Methods for estimating the occurrence of polypharmacy by means of a prescription database | Q61964815 | ||
| RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 | Q69755626 | ||
| Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators | Q72232746 | ||
| The effect of digoxin on mortality and morbidity in patients with heart failure | Q73080377 | ||
| P433 | issue | 2 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 212-219 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Current heart failure reports | Q26842297 |
| P1476 | title | Polypharmacy in heart failure patients | |
| P478 | volume | 11 |
| Q91925011 | "Whatever happens, happens" challenges of end-of-life communication from the perspective of older adults and family caregivers: a Qualitative study |
| Q38384130 | Association Between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients With Heart Failure |
| Q28076170 | Atrial fibrillation management in older heart failure patients: a complex clinical problem |
| Q55031909 | Clinical findings and survival time in dogs with advanced heart failure. |
| Q88733153 | Current drug therapy for heart failure with reduced ejection fraction |
| Q49707624 | Diseases Linked to Polypharmacy in Elderly Patients |
| Q57799329 | Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia |
| Q50014420 | Drug treatment of heart failure in the elderly |
| Q57171831 | Facilitators of and Barriers to mHealth Adoption in Older Adults With Heart Failure |
| Q35184792 | Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania |
| Q38855941 | Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines. |
| Q38669556 | Heart rate and its reduction in chronic heart failure and beyond |
| Q41808958 | Medication regimen complexity in ambulatory older adults with heart failure |
| Q33879548 | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management |
| Q35855340 | Predictors of medication nonadherence differ among black and white patients with heart failure |
| Q39148915 | Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure |
| Q58264954 | Self-care Activation, Social Support, and Self-care Behaviors among Women Living with Heart Failure |
| Q30855803 | Understanding heart failure; explaining telehealth - a hermeneutic systematic review |
| Q42374534 | What is polypharmacy? A systematic review of definitions. |
| Q33944629 | What puts heart failure patients at risk for poor medication adherence? |
| Q35792547 | Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials |
Search more.